Tofacitinib for the treatment of alopecia areata in preadolescent children Brittany G. Craiglow, MD, Brett A. King, MD, PhD Journal of the American Academy of Dermatology Volume 80, Issue 2, Pages 568-570 (February 2019) DOI: 10.1016/j.jaad.2018.08.041 Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 Response to treatment. Patient 1 at baseline (left), 6 months (center), and 9 months (right) of treatment with tofacitinib, 5 mg twice daily. Journal of the American Academy of Dermatology 2019 80, 568-570DOI: (10.1016/j.jaad.2018.08.041) Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions